New genetic vaccines using self-replicative RNA

Self-replicative RNA vaccines are capable of protecting mice against influenza A, respiratory syncytial virus (RSV), and a tick-borne encephalitis virus.

Tudor Toma(ttoma@mail.dntis.ro)
May 8, 2001

The discovery that naked plasmid DNA can elicit humoral and cellular immunity has prompted the development of genetic vaccines against many viruses for which no prevention currently exists. In the 1 May Journal of Infectious Diseases, Marina Fleeton and colleagues from the Karolinska Institute in Stockholm suggest the possibility of using the recombinant alpha virus RNA molecule — which replicates in the cytoplasm of transfected cells — as a novel approach in genetic vaccine development.

Fleeton et al immunized mice with recombinant Semliki Forest virus RNA encoding envelope proteins from influenza A, RSV or tick-borne encephalitis virus and found that antigen-specific antibody responses occurred after vaccination. IgG isotyping indicated that predominantly Th1 type immune responses were induced following immunization with RNA encoding the RSV F protein, suggesting protection against RSV infection had been generated. Challenge infection showed that RNA immunization had elicited significant levels of protection against the 3...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?